|
CA2683858A1
|
|
Ergothioneine and/or its derivatives as a cell preservative
|
|
WO2008109831A1
|
|
Use of ergothioneine as a preservative in foods and beverages
|
|
WO2004108009A2
|
|
Method and kit for assessing risk for bovine respiratory disease
|
|
WO03099277A1
|
|
Method of reducing incidence diabetic embryopathy with l-ergothioneine
|
|
CA2480227A1
|
|
Neuroprotectant methods, compositions, and screening methods thereof
|
|
US6407083B1
|
|
Uses of novel organoselenium compounds with pro-oxidant activity
|
|
US6235495B1
|
|
Methods for the quantitation of oxidized glutathione
|
|
US6010685A
|
|
Skin protectant comprising 5-substituted and 5,5-disubstituted 3,4-dihydroxy-2(5H)-furanones
|
|
CA2281799A1
|
|
Methods and compositions for the protection of mitochondria
|
|
US6103746A
|
|
Methods and compositions for the protection of mitochondria
|
|
US6005000A
|
|
5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use therefor
|
|
US5952187A
|
|
Topiramate immunoassay
|
